Dapabite M 10mg/500mg Tablet ER
Marketer
Corona Remedies Pvt Ltd
Salt Composition
Dapagliflozin (10mg) + Metformin (500mg)
Overview Dapabite M 10mg/500mg Tablet ER
Dapi-Comb 10mg/500mg Extended-Release Tablets combine two medications to manage type 2 diabetes. This dual-action therapy regulates elevated blood glucose, lessening the likelihood of severe diabetic complications and contributing to cardiovascular health. Dapi-Comb 10mg/500mg ER tablets can be taken with food, consistently at the same time daily for optimal adherence. Dosage is determined by your physician; discontinuation requires medical consultation as abrupt cessation may elevate blood sugar, risking kidney impairment or vision loss. This medication is one element of a comprehensive treatment strategy encompassing a doctor-recommended diet, exercise, and weight management plan. Common side effects include throat irritation, nasal stuffiness, rhinorrhea, headache, nausea, emesis, and diarrhea. Adequate hydration minimizes dehydration risk. Genital fungal infections are possible; proper hygiene is preventative. Prior to initiating treatment, disclose any renal or hepatic dysfunction, urinary tract infections, or diuretic use to your doctor. Pregnant or lactating individuals require medical counsel. Limit alcohol consumption, as it can intensify certain side effects. Regular blood glucose monitoring is essential throughout treatment.
Primary Ingredients of Dapabite M 10mg/500mg Tablet ER
There is no text provided to rephrase. Please provide the text you would like me to rewrite.
Uses of Dapabite M 10mg/500mg Tablet ER
Managing type 2 diabetes
Major Benefits of Dapabite M 10mg/500mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Dapabite M 10mg/500mg Extended-Release tablet whole; do not chew, crush, or divide it. Administer this medication with a meal.
Common Side effects of Dapabite M 10mg/500mg Tablet ER:
- Nausea
- Vomiting
- Diarrhea
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Polyuria
- Flatulence
- Skin rash
- Taste change
- Difficulty in urination
- Hypoglycemia (low blood glucose level)
- Tremors
- Dizziness
- Back pain
- Increased hematocrit
- Decreased creatinine clearance
- Dyslipidemia
How to use Dapabite M 10mg/500mg Tablet ER:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. It's recommended to take Dapabite M 10mg/500mg Extended-Release Tablet with food.
How Dapabite M 10mg/500mg Tablet ER works:
Dapagliflozin and Metformin, combined as Dapabite M 10mg/500mg Extended-Release tablets, offer enhanced blood glucose management. Dapagliflozin facilitates urinary glucose excretion, while Metformin reduces hepatic glucose production, slows intestinal glucose uptake, and improves insulin responsiveness. This dual action leads to superior glycemic control.
SAFETY ADVICE
AlcoholUNSAFE
Combining Dapabite M 10mg/500mg Tablet ER with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The extended-release Dapabite M 10mg/500mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Dapabite M 10mg/500mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if you experience such symptoms.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Dapabite M 10mg/500mg Extended-Release tablets. Dosage modification of Dapabite M 10mg/500mg Extended-Release tablets may be necessary. Physician consultation is recommended.
LiverCAUTION
Patients with hepatic impairment should use Dapabite M 10mg/500mg Extended-Release tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Dapabite M 10mg/500mg Tablet ER :
Should you forget to take your Dapabite M 10mg/500mg Extended-Release tablet, administer it immediately upon remembrance. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Dapabite M 10mg/500mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Treatment |



